203 related articles for article (PubMed ID: 1914226)
1. Serum soluble CD4 and CD8 levels in Kawasaki disease.
Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
[TBL] [Abstract][Full Text] [Related]
2. [Serum soluble CD4 and CD8 levels in Kawasaki disease].
Motohashi T
Arerugi; 1992 Feb; 41(2 Pt 1):140-7. PubMed ID: 1567283
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
4. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
[TBL] [Abstract][Full Text] [Related]
5. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
[TBL] [Abstract][Full Text] [Related]
6. [Serum soluble CD2, CD4 and CD8 levels in infectious mononucleosis].
Motohashi T
Arerugi; 1993 Aug; 42(8):926-33. PubMed ID: 7902699
[TBL] [Abstract][Full Text] [Related]
7. Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.
Sawada S; Hashimoto H; Iijima S; Tokano Y; Takei M; Shida M; Obara T
J Clin Lab Anal; 1993; 7(3):141-6. PubMed ID: 8509943
[TBL] [Abstract][Full Text] [Related]
8. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.
Vitale G; Mocciaro C; Malta R; Gambino G; Spinelli A; Giordano C; Stassi G; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1994 Aug; 97(2):280-3. PubMed ID: 8050177
[TBL] [Abstract][Full Text] [Related]
10. [Soluble lymphocyte antigens in hematological diseases].
Yoneyama A; Higashihara M; Nakahara K
Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
[TBL] [Abstract][Full Text] [Related]
11. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T
Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
Balázs C; Bokk A; Farid NR
Thyroid; 1994; 4(1):27-30. PubMed ID: 8054859
[TBL] [Abstract][Full Text] [Related]
13. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1991 Dec; 35(1-3):285-93. PubMed ID: 1955570
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
16. [Serum interleukin-2 receptor in patients with Kawasaki disease].
Matsubara T
Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
[TBL] [Abstract][Full Text] [Related]
17. CD8 serum levels in acute graft-versus-host disease diagnosis.
Bavaro P; Bonfini T; Di Girolamo G; Angelini A; Di Bartolomeo P; Angrilli F; Papalinetti G; Olioso P; Torlontano G
J Clin Immunol; 1994 Jul; 14(4):224-8. PubMed ID: 7929696
[TBL] [Abstract][Full Text] [Related]
18. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
[TBL] [Abstract][Full Text] [Related]
19. Immune function in patients with acute pancreatitis.
Uehara S; Gothoh K; Handa H; Tomita H; Tomita Y
J Gastroenterol Hepatol; 2003 Apr; 18(4):363-70. PubMed ID: 12653883
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
